Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04318639 · ClinicalTrials.gov registry record · Phase 2
The Combination of Donepezil and Cognitive Training for Treating Alcohol Use Disorder
A Phase 2 study, sponsored by VA Connecticut Healthcare System.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT04318639: Completed Phase 2 study, sponsored by VA Connecticut Healthcare System.
NCT04318639 is a Phase 2 study that has completed, run by VA Connecticut Healthcare System. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04318639, a Phase 2 study, has completed, sponsored by VA Connecticut Healthcare System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is an open label feasibility trial to learn whether the combination of donepezil and cognitive remediation therapy (Donepezil + CRT) may improve neurocognitive functioning and decreasing alcohol use in Veterans with alcohol use disorder who have mild cognitive impairment (AUD-MCI). The study will determine the acceptability and adherence to treatment and preliminary evidence for efficacy. The study will recruit 15 newly recovering Veterans individuals with AUD-MCI for a 13-week, open-label, single-arm pilot study with sobriety and cognitive assessments at baseline and at 13-week follow-up.
Interventions
- COMBINATION_PRODUCT Donepazil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-08-17 |
| Est. Completion | 2019-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04318639
The ClinicalTrials.gov registry entry for NCT04318639 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Connecticut Healthcare System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Donepazil is the first listed.
NCT04318639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04318639 about?
NCT04318639 is a clinical study titled "The Combination of Donepezil and Cognitive Training for Treating Alcohol Use Disorder". This is an open label feasibility trial to learn whether the combination of donepezil and cognitive remediation therapy (Donepezil + CRT) may improve neurocognitive functioning and decreasing alcohol use in Veterans with alcohol use disorder who have mild cognitive impairment (AUD-MCI). The study wi...
What is the current status of trial NCT04318639?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2018-08-17. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT04318639?
The interventions under investigation include: Donepazil (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04318639?
This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.